This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Investival Showcase London
Monday 16 November 2026
Old BillingsgateLondon, UK

Oliver Lyth
Associate at M Ventures
Speaker

Profile

Oliver Lyth joined M Ventures in 2024 and is currently an Associate in the Biotechnology investment team. Oliver leads diligence activities on prospective therapeutics investment opportunities and supports five M Ventures’ portfolio companies as Board Director (TwoStep Therapeutics) and Board Observer (Storm Therapeutics, iOnctura, Repronovo, and Future Fertility). Before joining M Ventures, Oliver acted as an Analyst in the due diligence team supporting LifeArc Ventures before joining IP Group’s Life Sciences Partnership as an Investment Manager. Oliver has an MBiochem from the University of Oxford and completed his PhD in Molecular Parasitology at Imperial College.

Agenda Sessions

  • Scaling Women's Health: Investment, Consolidation, and the Path Forward

    , 13:15